Company / Shareholders' Equity
Korro Bio, Inc. Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$160.4M
FY2025
5-year range
$130.8M / $192.5M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 6 years, ranging from -$48M in FY2019 to $192M in FY2021.
Based on SEC 10-K filings.
$160M in FY2025 with a 5-year CAGR of -0.8%.
Improved from $131M to $160M over the past 3 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +7.0%
- 5-Year CAGR
- -0.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.8%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 5.6% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $160.4M | -5.6% |
| FY2024 | $169.9M | +29.9% |
| FY2022 | $130.8M | -32.0% |
| FY2021 | $192.5M | +15.0% |
| FY2020 | $167.4M | +446.6% |
| FY2019 | -$48.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026